Home    Back

 307. Canavan disease
 [ 3 clinical trials,    4 drugs(DrugBank: 0 drug),    0 target gene / 0 target pathway

Searched query = "Canavan disease"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00657748September 20094 May 2015Lithium and Acetate for Canavan DiseaseEvaluation of the Tolerance and Efficiency of a Combined Oral Therapy With Lithium and GTA in Patients With Canavan DiseaseCanavan Disease;Infantile;Deficiency Disease;Aspartoacylase;Leukodystrophy, SpongiformDrug: Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)Assistance Publique - Hôpitaux de ParisEuropean Leukodystrophy Association;European Leukodystrophy AssociationNot recruiting1 Year15 YearsBoth0Phase 2France
2NCT00724802March 200819 February 2015Oral Glyceryl Triacetate (GTA) in Newborns With CanavanOral Glyceryl Triacetate (GTA) in Newborns With CanavanCanavan DiseaseDietary Supplement: GTA (Glyceryl triacetate);Drug: GTA glyceryl triacetateShaare Zedek Medical CenterRecruitingN/A18 MonthsBoth1N/AIsrael
3NCT00278707January 200619 February 2015GTA-Glyceryltriacetate for Canavan DiseasePhase 1 Treatment With GTA in Two Infant With Canavan DiseaseInfantile Canavan Disease;Deficiency Disease, AspartoacylaseDrug: GTA: GlyceryltriacetateSheba Medical CenterNot recruitingN/A15 MonthsBoth5Phase 1Israel